CTBBL - Overview: Mycobacterial Culture, Blood

Diagnosing mycobacteremia

MYCOM - Overview: Mycoplasma pneumoniae Antibodies, IgM, Serum

Screening for IgM antibodies in the indication of recent or past exposure to Mycoplasma pneumoniae

NMRLP - Overview: Nuclear Magnetic Resonance Lipoprotein Profile, Serum

Assessment and management of a patient's risk for atherosclerotic cardiovascular disease Identifying residual risk that may be present in some patients on cholesterol targeting treatment

NIU - Overview: Nickel, 24 Hour, Urine

Preferred test for biomonitoring patients for nickel exposure to minimize any potential diurnal variation

TPO - Overview: Thyroperoxidase Antibodies, Serum

Aiding in the diagnosis of thyroid autoimmune disorders Differentiating thyroid autoimmune disorders from nonautoimmune goiter or hypothyroidism As a diagnostic tool in deciding whether to treat a patient who has subclinical...

OXYSX - Overview: Oxycodone Screen, Chain of Custody, Random, Urine

Detection of oxycodone and oxymorphone in urine following chain-of-custody procedures This chain-of-custody test is intended to be used in a setting where the test results can be used definitively to make a diagnosis. Chain of custody is...

PBGD_ - Overview: Porphobilinogen Deaminase, Whole Blood

Confirmation of a diagnosis of acute intermittent porphyria

LDAI - Overview: Progentec aiSLE DX Lupus Disease Activity Index, Plasma

Aiding in the assessment of current systemic lupus erythematosus disease activity when used in conjunction with standard clinical assessment

PCAG - Overview: Protein C Antigen, Plasma

Differentiating congenital type I protein C deficiency from type II deficiency Evaluating the significance of decreased functional protein C, especially when decreased protein C activity might be congenital rather than acquired (eg, due...

PIK3T - Overview: PIK3CA Mutation Analysis, Tumor

Identification of hormone receptor positive and human epidermal growth factor receptor 2 negative (HR+/HER2-) advanced breast cancer tumors that may be eligible for treatment with targeted kinase inhibitor therapy (eg, alpelisib).